Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

9 Meters Biopharma, Inc. (NMTR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.2644+0.0144 (+5.76%)
At close: 04:00PM EDT
0.2600 -0.00 (-1.66%)
After hours: 07:32PM EDT
Advertisement
Full screen
Loading interactive chart...
  • ACCESSWIRE

    9 Meters Biopharma to Participate in the William Blair Biotech Focus Conference 2022

    RALEIGH, NC / ACCESSWIRE / July 6, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced today that John Temperato, President & Chief Executive Officer of 9 Meters, will participate in a fireside chat at the William Blair Biotech Focus Conference taking place on July 12 - 13, 2022, in New York City.

  • American City Business Journals

    Chapel Hill company given extension to regain Nasdaq compliance

    A medical device company that set up shop in Chapel Hill last year has received some relief in its bid to remain listed on the Nasdaq Capital Market.

  • ACCESSWIRE

    9 Meters Biopharma Announces Debt Facility to Support Phase 3 Study of Vurolenatide for Short Bowel Syndrome

    Initial Draw of $20 Million to Support Funding Phase 3 Development of Vurolenatide in Short Bowel SyndromeRALEIGH, NC / ACCESSWIRE / June 30, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced it has entered into a senior secured convertible notes facility with a single lender for up to $70 million that is part of an overall financing strategy to support the continued develop

Advertisement
Advertisement